Congratulations to Smilow/YNHH Team on $11M Oncology Research Grant

CSMS member Roy Herbst, MD recently received some excellent news.

Dr. Herbst, chief of medical oncology at YNHH/Smilow, and his team were awarded an $11M grant for their Specialized Program of Research Excellence (SPORE) focusing on non-small cell lung cancers.

“What this grant is designed to do is to take new therapies and discoveries from the lab to the patients who need them in the clinic and to raise the bar … to develop even better therapies for those who come after,” said Dr. Roy S. Herbst, chief of the medical oncology program at Smilow.

He emphasized that “my proudest thing about the program,” known as a Specialized Program of Research Excellence, is the team of 25 or so doctors and others who will focus on finding treatments for a disease “that kills 200,000 people a year in the United States.”

Click to read the full story in the New Haven Register.